Cargando…
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
Cancer treatment is rapidly evolving toward personalized medicine, which takes into account the individual molecular and genetic variability of tumors. Sophisticated new in vitro disease models, such as three-dimensional cell cultures, may provide a tool for genetic, epigenetic, biomedical, and phar...
Autores principales: | Colella, Gianluca, Fazioli, Flavio, Gallo, Michele, De Chiara, Annarosaria, Apice, Gaetano, Ruosi, Carlo, Cimmino, Amelia, de Nigris, Filomena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855837/ https://www.ncbi.nlm.nih.gov/pubmed/29466296 http://dx.doi.org/10.3390/ijms19020615 |
Ejemplares similares
-
Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone
por: Fazioli, Flavio, et al.
Publicado: (2017) -
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response
por: Mosca, Laura, et al.
Publicado: (2022) -
Ex Vivo Behaviour of Human Bone Tumor Endothelial Cells
por: Infante, Teresa, et al.
Publicado: (2013) -
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
por: Scognamiglio, Giosue, et al.
Publicado: (2019) -
Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients
por: Palinski, Wulf, et al.
Publicado: (2021)